The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,923.00
Bid: 1,922.00
Ask: 1,924.00
Change: -35.00 (-1.79%)
Spread: 2.00 (0.104%)
Open: 1,969.00
High: 1,972.00
Low: 1,921.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 27th Nov 2013 09:14

Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation.Bellway: Numis upgrades to buy with a target price of 1690p.Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation.Britvic: UBS ups target price from 575p to 600p and keeps a neutral rating. Barclays upgrades to overweight with a target price of 690p.BTG: Deutsche Bank takes target price from 500p to 570p reiterating a buy recommendation. Panmure Gordon raises target price from 490p to 610p and retains a buy recommendation. Investec ups target price from 472p to 723p and maintains a buy recommendation.Compass Group: Numis increases target price from 850p to 900p and stays with its hold recommendation. Panmure Gordon takes target price from 820p to 900p maintaining a hold recommendation.De La Rue: Citi lowers target price from 1055p to 1000p downgrading from buy to neutral. Panmure Gordon ups target price from 786p to 806p and keeps a hold recommendation.Essar Energy: Deutsche Bank cuts target price from 175p to 75p, while maintaining a hold recommendation.Hargreaves Lansdown: Numis ups target price from 1006p to 1027p and maintains a hold recommendation.Hikma Pharmaceuticals: Goldman Sachs raises target price from 1180p to 1200p and keeps a neutral rating.IGas Energy: Canaccord Genuity shifts target price from 181p to 180p and stays with its buy recommendation.Imagination Technologies: Jefferies reduces target price from 628p to 393p, while leaving its buy recommendation unchanged.Immunodiagnostic Systems: Investec ups target price from 466p to 494p keeping a hold recommendation.Innovation Group: Panmure Gordon shifts target price from 41p to 44p and reiterates a buy recommendation.Jardine Lloyd Thompson Group: Westhouse Securities initiates with a target price of 1130p and an add rating.Marshalls: Jefferies initiates with a target price of 166p and a hold recommendation.Mitchells & Butlers: Nomura ups target price from 370p to 390p and keeps a neutral rating. JP Morgan upgrades from underweight to neutral with a target price of 400p. Panmure Gordon increases target price from 310p to 365p, but still recommends selling.MITIE Group: UBS moves target price from 305p to 320p, while downgrading from buy to neutral.Mondi: Goodbody cuts target price from 1290p to 1240p and reiterates a buy recommendation.NMC Health: Numis ups target price from 500p to 560p and reiterates a buy recommendation.Rio Tinto: Canaccord Genuity reduces target price from 4100p to 4000p, while its buy recommendation remains unchanged.Royal Mail: Investec places its target price (prev.: 544p) under review, while staying with its hold recommendation.Severn Trent: Goldman Sachs shifts target price from 2113p to 2110p, while leaving its buy recommendation unaltered.Shaftesbury: Liberum Capital takes target price from 622p to 636p and retains a hold recommendation.Smith (DS): Citi moves target price from 300p to 340p maintaining a buy recommendation. Goodbody ups target price from 285p to 295p, while downgrading to hold.Tesco: JP Morgan lowers target price from 335p to 315p and retains an underweight rating.Topps Tiles: Cantor Fitzgerald downgrades to sell with a target price of 82p.Tyman: Jefferies initiates with a target price of 269p and a buy recommendation.VP: Cantor Fitzgerald raises target price from 490p to 570p retaining a buy recommendation.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.